Research Idea
Research content for general circulation. Not individualized advice. Methodology & Disclosures
Fresh 2026-07-28 Q2 upside surprise: EPS of $2.51 beat $0.89 expected, revenue and profit beat, net income topped $1B, and management raised the 2026 outlook. The earnings catalyst and healthcare defensiveness offset the still-recovering technical setup.
Loading chart data...
AI Analyst Overview
Loading chart data...
Valuation Metrics
Fundamental Analysis
Key Financial Insights: ⢠Profitability rebound ⢠Strong cash flow ⢠High leverage CNC's quarterly profitability, liquidity, and cash flow improved sharply, but elevated leverage and intangible-heavy equity warrant caution despite low sales/book valuation.
Price Behavior
Key Price Behavior Insights: ⢠Recent rebound ⢠Key support ⢠Overhead resistance Support Level: $64.00â$64.50 Resistance Level: $67.00â$68.00 CNC is cautiously bullish after rebounding from $64.06 to $66.42 over the last month, with support at $64.00â$64.50 and a sustained break above $67.00â$68.00 needed for stronger upside confirmation.
Sentiment & News
Key News Insights: ⢠Margin improvement ⢠Marketplace recovery ⢠Attractive valuation Centene's strong valuation, margin gains, Marketplace recovery, and rising earnings outlook support a favorable growth thesis.
AI Summary
CNC is an execution-driven margin-recovery opportunityânot a simple value playâwhere sustained 4.5%â5% pretax margins and positive earnings could unlock upside, but investors should wait for repeated proof that Marketplace/Medicaid pricing and medical costs remain favorable amid leverage and policy risk.
Description
Centene Corporation is a multinational healthcare company that provides programs and services primarily for under-insured and uninsured individuals in the U.S., delivering government-funded managed care across Medicaid, CHIP, long-term services and supports, foster care, and plans for dually eligible and disabled populations, alongside commercial insurance products. Its offerings span clinical and non-clinical care coordination, pharmacy and behavioral health services, telehealth and home-based care, and supplemental services for vision, dental and transportation; a separate specialty-services unit provides pharmacy benefits management, nurse advice lines, correctional and military health support, and related staffing. The company was founded in 1984 and is headquartered in St. Louis, Missouri.
Idea History
| Date | Close | Ticker | Company | Summary | Status | P/L |
|---|---|---|---|---|---|---|
| Jul 28 | Aug 4 | CNC | Centene Corporation | Fresh 2026-07-28 Q2 upside surprise: EPS of $2.51 beat $0.89 expected, revenue and profit beat, net income topped $1B, and management raised the 2026 outlook. The earnings catalyst and healthcare defensiveness offset the still-recovering technical setup. | Closed | +0.3% |
| Apr 28 | May 5 | CNC | Centene Corporation | Managed-care momentum with policy catalyst: Q1 2026 adjusted EPS of $3.37 beat expectations and full-year 2026 guidance was raised to above $3.40 adjusted EPS, while finalized Medicare Advantage payment increases improved reimbursement sentiment. | Closed | +6.9% |